Original Article
The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer
N Engl J Med 2001; 345:1719-1726December 13, 2001
- Abstract
Background
Supportive–expressive group therapy has been reported to prolong survival among women with metastatic breast cancer. However, in recent studies, various psychosocial interventions have not prolonged survival.
Methods
In a multicenter trial, we randomly assigned 235 women with metastatic breast cancer who were expected to survive at least three months in a 2:1 ratio to an intervention group that participated in weekly supportive–expressive group therapy (158 women) or to a control group that received no such intervention (77 women). All the women received educational materials and any medical or psychosocial care that was deemed necessary. The primary outcome was survival; psychosocial function was assessed by self-reported questionnaires.
Results
Women assigned to supportive–expressive therapy had greater improvement in psychological symptoms and reported less pain (P=0.04) than women in the control group. A significant interaction of treatment-group assignment with base-line psychological score was found (P≤0.003 for the comparison of mood variables; P=0.04 for the comparison of pain); women who were more distressed benefited, whereas those who were less distressed did not. The psychological intervention did not prolong survival (median survival, 17.9 months in the intervention group and 17.6 months in the control group; hazard ratio for death according to the univariate analysis, 1.06 [95 percent confidence interval, 0.78 to 1.45]; hazard ratio according to the multivariate analysis, 1.23 [95 percent confidence interval, 0.88 to 1.72]).
Conclusions
Supportive–expressive group therapy does not prolong survival in women with metastatic breast cancer. It improves mood and the perception of pain, particularly in women who are initially more distressed.
Media in This Article
Figure 2
Kaplan–Meier Survival Curves for Women Assigned to the Intervention Group and the Control Group.Figure 1
Interaction between Base-Line Score and the Effect of the Study Intervention in Terms of Total Mood Disturbance (Top Panels) and Perception of Pain (Bottom Panels).Article Activity
- Article
In 1989, Spiegel et al.1 reported a randomized trial of supportive–expressive group therapy in women with metastatic breast cancer. Supportive–expressive group therapy is a standardized treatment for those with life-threatening illness that encourages participants to express feelings and concerns about their illness and its effect on their lives in the supportive environment of a therapist-led group. The women who participated in such therapy lived a mean of 18 months longer than the women in the control group.2,3 However, since the statistical analysis of survival had not been planned, these results called for further investigation. Two recent randomized trials of two different psychosocial interventions for women with metastatic breast cancer4-7 did not show that group therapy prolongs survival, although transient positive effects on mood and self-esteem were found.5 Results of other randomized studies of psychosocial interventions in cancer patients have been inconsistent.8-11
In the Breast Expressive–Supportive Therapy Study, we attempted to replicate Spiegel's results.1 Our primary objective was to determine whether the addition of supportive–expressive group therapy to routine care influenced the survival of women with metastatic breast cancer. Secondary outcomes were psychological functioning (e.g., mood, social support, and adjustment to illness), experience of pain, and the quality of life. In this article we report the results of the intervention in terms of survival, mood, and pain — the three elements that Spiegel et al. reported were affected by the intervention.2,3 Effects on the quality of life and other psychosocial outcomes will be reported separately.
Methods
Study Protocol
The trial was coordinated at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, University of Toronto, Toronto. Other participating centers, all in Canada, included the Hamilton Regional Cancer Center, Hamilton, Ontario; the Ottawa Regional Cancer Center, Ottawa, Ontario; CancerCare Manitoba, Winnipeg; the Tom Baker Cancer Center, Calgary, Alberta; the British Columbia Cancer Agency, Vancouver; and Cross Cancer Institute, Edmonton, Alberta. Approval was obtained from the ethics committees of all participating centers; all the women provided written informed consent.
Women were recruited between 1993 and 1998. They were eligible if they had histologic confirmation of breast cancer at the time of diagnosis, if they had metastases outside of the breast and ipsilateral axilla, and if the treating physician most responsible for a woman's care gave consent. Women were excluded if they met any of the following criteria: central nervous system metastases; active psychosis, untreated major depression, or severe character disorder (assessed at a prerandomization interview); planned participation in a therapist-led support group for patients with metastatic breast cancer outside of the study center (no such groups existed at the study centers when the study began); residence more than one hour from the study center; life expectancy of less than three months as assessed by the treating oncologist; or an inability to speak and read English. Potentially eligible women completed base-line psychosocial questionnaires and met with group leaders for psychological assessment. A detailed report regarding recruitment has been published elsewhere.12
Women in the intervention group attended weekly meetings lasting 90 minutes. Each group consisted of 8 to 12 women and two leaders. The leaders were psychiatrists, psychologists, social workers, or nurse clinicians who were experienced in leading group therapy; at least one of the two leaders in each group was a woman. The therapy was intended to foster support among group members and to encourage the expression of emotions about cancer and its broad-ranging effects on their lives (physical, emotional, social, and spiritual).13,14 Women were encouraged to interact with each other and to support each other outside of the group sessions. Participants were given the opportunity and support to speak about the effects of the illness, its treatment, and changes in their self-image, roles, and relationships with family members, friends, coworkers, health care providers, and others. The women also discussed the life-altering nature of the illness and strategies for coping and communicating. They were asked to attend the group sessions for at least one year, or longer if the sessions continued to be of benefit. A monthly 90-minute session was provided for family and friends.
Leaders received standardized training consisting of a detailed review of a therapy manual by Spiegel and Spira,13 2-day workshops (attended by David Spiegel or his associate Catherine Classen) every 9 to 12 months that included discussion of therapeutic principles and reviews of videotaped sessions, and monthly review of a videotape of randomly selected sessions, with written feedback to promote the consistent delivery of the intervention.
Women in the control group did not receive any psychological therapy as part of the study. Women in either group could participate in peer support groups, or therapist-led support groups for patients with various types of cancer that did not involve supportive–expressive therapy, and they could receive any necessary medical, surgical, or psychosocial care. Every four to six months, all the women received educational materials about breast cancer and its treatment, as well as about relaxation and nutrition.
The primary outcome was survival; a secondary outcome was psychosocial function. Detailed information regarding medical status (vital status and Eastern Cooperative Oncology Group [ECOG] performance status), treatment received (chemotherapy, hormone therapy, radiation therapy, surgery, palliation, or other), and sites of metastatic disease was collected at study entry and every four months thereafter. These data were reviewed and coded centrally.
At base line and at 4, 8, and 12 months, the women were asked to complete psychosocial questionnaires that included the Profile of Mood States15 and the pain and suffering scales used by Spiegel and Bloom.3 They also provided information on their demographic characteristics and social support.
The calculation of the sample size was based on an expected three-year survival of 15 percent in the control group and 30 percent in the intervention group, a type I error of 0.05 (two-tailed), a power of 80 percent, and a randomization ratio of 2:1 (intervention group:control group). These assumptions yielded a sample size of 256 women (with an expected 205 deaths). Because recruitment was slower than expected, the follow-up period was longer than anticipated, and recruitment ended when we had enrolled 237 women. Analysis was performed after 201 deaths had occurred. Power calculations based on the prolonged follow-up period confirmed that the study had 85 percent power to identify an effect of the size specified a priori.
Randomization
Randomization, performed centrally with the use of sealed envelopes containing allocations from a computer-generated table of random numbers, was stratified according to the center (seven sites) and the presence or absence of visceral metastases. A 2:1 ratio of randomization (intervention group:control group) was used. In order to form an initial support group at each center, 14 to 18 women underwent randomization simultaneously. Once the support groups had been established, newly enrolled women underwent randomization individually. A total of 237 women underwent randomization. Two of them were found to be ineligible — one woman assigned to the control group did not have metastases, and one woman assigned to the intervention group had a carcinoid tumor. These women were excluded from the analysis.
Masking
No blinding was used in randomization or data collection. Psychosocial questionnaires were scored by a research assistant who had no knowledge of the subjects' treatment assignment.
Statistical Analysis
Descriptive statistics were generated for all variables. Continuous variables with skewed distributions were transformed as follows: for the years from diagnosis to the first metastasis, the years from the first diagnosis of breast cancer to randomization, and all the Profile of Mood States subscales except the vigor–activity subscale, the square root was used; for the years from the first metastasis to randomization and for base-line pain, the log value was used. These transformations were reversed for the presentation of results. Two-sample t-tests were used for the comparison of continuous variables, and Pearson's chi-square tests were used for the comparison of categorical variables.
The psychosocial analyses included the 218 women who completed base-line questionnaires during the four months before randomization. Follow-up scores from the 15-month period after randomization were averaged, and any change during the course of 1 year was calculated by subtracting the base-line scores from these averages. Changes were compared with the use of two-sample t-tests. Two sets of analyses of covariance were performed, the first one excluding interaction terms and the second one including these terms to allow treatment effects to depend on base-line status.
Univariate and multivariate Cox proportional-hazards models, stratified according to the study center and the presence of visceral or nonvisceral metastases at randomization, were used to assess effects on survival. The multivariate Cox model included factors that differed between groups at base line (age at diagnosis, nodal stage, the presence or absence of estrogen receptors and progesterone receptors, and the use or nonuse of adjuvant chemotherapy) and the time from the first metastasis to randomization.
An intention-to-treat approach was used for all analyses. Interim analyses were neither planned nor performed.
Results
Intervention and Follow-up
Of the 235 women who entered the study, 158 were assigned to the intervention group and 77 to the control group. Attendance at group-therapy sessions averaged 66.7 percent (3475 of 5208 possible person-sessions) and did not differ significantly among centers. The most common reasons for nonattendance were ill health, a need for medical treatment, and the inability to travel. Thirty women (19.0 percent) dropped out of group therapy after a mean of 3.5 months, and eight women did not attend any sessions. Participation after randomization in support groups outside of the study was reported by 8.2 percent of the women in the intervention group (13 of 158 women) and 10.4 percent of those in the control group (8 of 77 women, P=0.59). The rate of completion of the psychosocial questionnaires did not differ significantly between the two groups (70.5 percent of the women in the intervention group and 65.3 percent of those in the control group completed at least one follow-up questionnaire, P=0.43). Data on survival were available for all women.
Characteristics of the Subjects
Features of the two groups are shown in Table 1Table 1
Characteristics of the Study Population at Randomization. and Table 2Table 2
Characteristics of the Study Population at the Time of the Initial Diagnosis of Breast Cancer.. The groups were balanced in terms of the characteristics of the tumors and the treatments being received at the time of randomization. Women in the intervention group were younger than those in the control group at the time of diagnosis (mean age, 44.0 vs. 46.6 years; P=0.04) and were less likely to be postmenopausal (14.6 percent vs. 33.8 percent, P=0.001). They were also more likely to have had involvement of axillary nodes (70.9 percent vs. 50.7 percent, P=0.002). The tumors of the women in the intervention group were more likely to have had estrogen receptors (69.0 vs. 54.5, P=0.06) and progesterone receptors (63.9 percent vs. 42.9 percent, P=0.01), and the use of adjuvant chemotherapy was more common in the intervention group (75.9 percent vs. 55.6 percent, P=0.01). Only progesterone-receptor status was associated with survival (P=0.02); the imbalance in the distribution of this characteristic favored longer survival in the intervention group (data not shown).Profile of Mood States
The Profile of Mood States15 is a self-administered questionnaire containing 65 items scored on a 5-point scale from “not at all” (0) to “extremely” (4). Items are grouped into six subscales and combined into a total mood-disturbance scale. At base line, the scores for depression–dejection, tension–anxiety, and anger–hostility were not significantly different in the two groups (Table 3Table 3
Profile of Mood States.). However, scores during the year after randomization for total mood disturbance (P=0.02), depression–dejection (P=0.002), tension–anxiety (P=0.002), anger–hostility (P=0.007), and confusion–bewilderment (P=0.02) were significantly lower in the intervention group than in the control group. Adjustment for base-line inequalities diminished these differences but revealed a significant interaction between base-line score and effect of treatment. Women who were initially more distressed benefited from the intervention, whereas women who were not as distressed did not benefit (Figure 1Figure 1Interaction between Base-Line Score and the Effect of the Study Intervention in Terms of Total Mood Disturbance (Top Panels) and Perception of Pain (Bottom Panels).). The magnitude of the benefit in the more distressed women was 13.5 percent of the possible range of the scale. Scores for depression–dejection, tension–anxiety, anger–hostility, and confusion–bewilderment followed a similar course, but there were no significant differences in fatigue–inertia or vigor–activity. There were no significant interactions between treatment and study center in terms of total mood disturbance or any subscale.Experience of Pain and Suffering or Hurt
Women recorded their “experience of pain and of suffering or hurt at this moment” on two 10-cm visual-analogue scales; the scale for the assessment of pain ranged from “not noticeable” to “excruciating — worst ever,” and the scale for assessment of suffering or hurt ranged from “easily bearable” to “agonizing — unbearable.”3 Base-line scores were low (Table 4Table 4
Experience of Pain and of Suffering or Hurt.), and the women in the intervention group reported less worsening of pain over the course of one year than the controls did (P=0.04). There was a significant interaction between treatment and base-line score (P=0.04); women in the intervention group benefited only if their base-line scores were high (Figure 1). The magnitude of the benefit in these women was 15 percent of the range of the scale (1.54 cm). There were no significant differences in the experience of suffering or hurt. No significant interactions between treatment and study center existed for either variable. The use of analgesics, palliative radiation, or other therapy was not considered in this evaluation of pain.Survival
Kaplan–Meier survival analysis showed that the median survival was 17.9 months in the intervention group and 17.6 months in the control group (Figure 2Figure 2
Kaplan–Meier Survival Curves for Women Assigned to the Intervention Group and the Control Group.). According to the univariate Cox model, the hazard ratio for death in the intervention group as compared with the control group was 1.06 (95 percent confidence interval, 0.78 to 1.45; P=0.72).A multivariate Cox model identified no significant effect of the intervention on survival (hazard ratio, 1.23; 95 percent confidence interval, 0.88 to 1.72; P=0.22). Other variables included in the multivariate model were the presence or absence of progesterone receptors (P=0.01), the presence or absence of estrogen receptors (P=0.71), the time from first metastasis to randomization (P=0.50), age at diagnosis (P=0.85), nodal stage at diagnosis (P=0.40), and the use or nonuse of adjuvant chemotherapy (P=0.11). No significant interactions with treatment were identified for study center, marital status, or base-line total mood-disturbance score (P=0.51, P=0.26, and P=0.83, respectively). The effects of the intervention remained nonsignificant after adjustment for each of these variables.
Discussion
The addition of supportive–expressive group therapy to standard care for women with metastatic breast cancer did not influence survival in our study. Women in the intervention group were younger than the controls and were more likely to have had nodal involvement and to have received adjuvant chemotherapy at the time of diagnosis, but these factors were not associated with the primary outcome. The presence of progesterone receptors in the tumor was more frequent in the intervention group, which favored longer survival; however, the inclusion of progesterone-receptor status in the multivariate analysis actually increased the hazard ratio for death, making a beneficial effect of the intervention on survival less likely. Minor differences in base-line mood did not influence these results. For these reasons, we do not believe that the imbalances between study groups vitiated the statistical analysis.
It is unlikely that an important effect on survival was missed because of inadequate power; our study had 99 percent power to identify a 25 percent improvement in three-year survival — the size of the improvement reported by Spiegel et al.1 — and 85 percent power to identify the 15 percent improvement in three-year survival we had specified a priori. Nor was such an effect likely to be missed because of poor group participation; 95 percent of the women in the intervention group attended at least one group-therapy session, and 81 percent remained involved throughout the first year. Thus, our findings do not support the observation by Spiegel et al.1 that supportive–expressive group therapy prolongs survival in women with metastatic breast cancer. Our results are, by contrast, consistent with those of Cunningham et al.4 and Edelman et al.7 indicating that psychosocial interventions do not prolong survival in women with metastatic breast cancer.
There were, however, psychosocial benefits of supportive–expressive therapy in women with metastatic breast cancer. The more distressed women benefited from the intervention, whereas those who were not so distressed did not, perhaps because of a “floor effect” (i.e., the response options on the questionnaires focused on distress and were not sufficiently broad to detect improvement when base-line distress was low); however, no woman had a base-line score of zero, and any worsening of scores (which would be likely when the medical status deteriorated) would have been readily detected.
The beneficial effect of the intervention on the experience of pain may have been attributable to the exercise in self-hypnosis and relaxation performed at the end of each group session, but other mechanisms are possible. During the sessions, the leaders did not intervene in the medical treatment of group members. However, when a woman expressed a concern about pain, the leaders responded by discussing the physical and emotional benefits of good pain control and fears of narcotic addiction. They encouraged members to discuss their pain management more fully with their physicians, who may have taken steps to improve pain control.
The beneficial psychosocial effects of our intervention are consistent with previous reports of the benefits of supportive–expressive therapy2,3,17 and other psychosocial interventions5,18 in metastatic breast cancer. These beneficial effects are evidence that supportive–expressive group therapy was delivered effectively in our study. On the basis of population-based data, we estimate that we randomly assigned 8.6 percent of potentially eligible women to treatment groups — a proportion that is in line with rates of 3 to 12 percent for chemotherapy and radiation-therapy trials.16,19,20 Nevertheless, we do not know whether our results are generalizable with respect to psychological factors. If our participants were more (or less) distressed than nonparticipants, the beneficial psychological effects we identified may not be representative. However, we cannot clarify this point because ethical considerations did not permit the collection of psychological information regarding nonparticipants.
Funded by the Medical Research Council of Canada (now the Canadian Institutes of Health Research) and the Canadian Breast Cancer Research Initiative.
We are indebted to Drs. David Spiegel and Catherine Classen of Stanford University for their help in teaching the principles of supportive–expressive group therapy to our group leaders and for their support throughout the study.
Source Information
From the Departments of Medicine (P.J.G.), Psychiatry (M.L., J.H.), and Nursing (L.V.), and the Division of Clinical Epidemiology at the Samuel Lunenfeld Research Institute (P.J.G., M.E.), Mount Sinai Hospital, University of Toronto, Toronto; the Department of Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, Alta. (J.K., M.S.); the Department of Supportive Care, Hamilton Regional Cancer Center, Hamilton, Ont. (H.G.); the Department of Psychiatry, University of British Columbia, Vancouver, and the British Columbia Cancer Agency, Vancouver (E.D.); the Department of Psychology, University of Alberta, Edmonton, and the Cross Cancer Institute, Edmonton, Alta. (M.H.); the Department of Psychiatry, University of Manitoba, Winnipeg, and CancerCare Manitoba, Winnipeg (H.M.C.); and the Department of Psychiatry, University of Ottawa, and the Ottawa Regional Cancer Center, Ottawa, Ont. (M.N.) — all in Canada.
Address reprint requests to Dr. Goodwin at Mount Sinai Hospital, 1284-600 University Ave., Toronto, ON M5G 1X5, Canada, or at pgoodwin@mtsinai.on.ca.
Other authors were Julia Masterson, M.D., Department of Supportive Care, Hamilton Regional Cancer Center, Hamilton, Ont.; Liz Dohan, M.S.W., Department of Patient and Family Counseling, British Columbia Cancer Agency, Vancouver; Rami Sela, Ph.D., Department of Psychology, University of Alberta, Edmonton; Barbara Warren, R.N., M.S.N., CancerCare Manitoba, Winnipeg; Alexander Paterson, M.D., Department of Oncology, University of Calgary, Calgary, Alta.; Kathleen I. Pritchard, M.D., Department of Medicine, and Andrew Arnold, M.B., B.S., Department of Oncology, Mount Sinai Hospital, University of Toronto, Toronto; Richard Doll, M.S.W., Department of Patient and Family Counseling, and Susan E. O'Reilly, M.D., Department of Oncology, British Columbia Cancer Agency, Vancouver; and Gail Quirt, R.N., B.A.A., and Nicky Hood, R.N., Mount Sinai Hospital, University of Toronto, Toronto — all in Canada.
- References
References
1
Spiegel D ,Bloom JR ,Kraemer HC ,Gottheil E . Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989;2:888-891
CrossRef | Web of Science | Medline2
Spiegel D ,Bloom JR ,Yalom I . Group support for patients with metastatic cancer: a randomized outcome study. Arch Gen Psychiatry 1981;38:527-533
Web of Science | Medline3
Spiegel D ,Bloom JR . Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 1983;45:333-339
Web of Science | Medline4
Cunningham AJ ,Edmonds CV ,Jenkins GP ,Pollack H ,Lockwood GA ,Warr DA . A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology 1998;7:508-517
CrossRef | Web of Science | Medline5
Edelman S ,Bell DR ,Kidman AD . A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology 1999;8:295-305
CrossRef | Web of Science | Medline6
Edmonds CV ,Lockwood GA ,Cunningham AJ . Psychological response to long-term group therapy: a randomized trial with metastatic breast cancer patients. Psychooncology 1999;8:74-91
CrossRef | Web of Science | Medline7
Edelman S ,Lemon J ,Bell DR ,Kidman AD . Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology 1999;8:474-481
CrossRef | Web of Science | Medline8
Fawzy FI ,Fawzy NW ,Hyun CS , et al. Malignant melanoma -- effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993;50:681-689
Web of Science | Medline9
Kuchler T ,Henne-Bruns D ,Rappat S , et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 1999;46:322-335
Web of Science | Medline10
Ilnyckyj A ,Farber J ,Cheang MC ,Weinerman BH . A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann R Coll Physicians Surg Can 1994;27:93-9611
Linn MW ,Linn BS ,Harris R . Effects of counseling for late stage cancer patients. Cancer 1982;49:1048-1055
CrossRef | Web of Science | Medline12
Goodwin PJ ,Leszcz M ,Quirt G , et al. Lessons learned from enrollment in the BEST study -- a multicenter, randomized trial of group psychosocial support in metastatic breast cancer. J Clin Epidemiol 2000;53:47-55
CrossRef | Web of Science | Medline13
Spiegel D, Spira J. Supportive-expressive group therapy: a treatment manual of psychosocial intervention for women with recurrent breast cancer. Stanford, Calif.: Psychosocial Treatment Laboratory, Stanford University School of Medicine, 1991.
14
Leszcz M ,Goodwin PJ . The rationale and foundations of group psychotherapy for women with metastatic breast cancer. Int J Group Psychother 1998;48:245-273
Web of Science | Medline15
McNair DM, Lorr M, Droppleman LF. EdITS manual for the Profile of Mood States. Rev. ed. San Diego, Calif.: Educational and Industrial Testing Service, 1992.
16
Friedman MA ,Cain DF . National Cancer Institute sponsored cooperative clinical trials. Cancer 1990;65:Suppl:2376-2382
CrossRef | Web of Science | Medline17
Classen C ,Butler LD ,Koopman C , et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry 2001;58:494-501
CrossRef | Web of Science | Medline18
Fukui S ,Kugaya A ,Okamura H , et al. A psychosocial group intervention for Japanese women with primary breast carcinoma. Cancer 2000;89:1026-1036
CrossRef | Web of Science | Medline19
Tate HC ,Rawlinson JB ,Freedman LS . Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet 1979;2:623-625
CrossRef | Web of Science | Medline20
Twelves CJ ,Thomson CS ,Young J ,Gould A . Entry into clinical trials in breast cancer: the importance of specialist teams. Eur J Cancer 1998;34:1004-1007
CrossRef | Web of Science | Medline
- Citing Articles (213)
Citing Articles
1
Kathleen T. Durant, Alexa T. McCray, Charles Safran. (2013) Identifying Temporal Changes and Topics that Promote Growth Within Online Communities. International Journal of Computational Models and Algorithms in Medicine 2:2, 1-22
CrossRef2
Yaira Hamama-Raz, Shlomit Perry, Ruthy Pat-Horenczyk, Ruth Bar-Levav, Solomon M. Stemmer. (2012) Factors affecting participation in group intervention in patients after adjuvant treatment for early-study breast cancer. Acta Oncologica 51:2, 208-214
CrossRef3
J. Hefner, H. Csef. (2012) Psychoneuroimmunologie und Krebs. best practice onkologie 7:1, 18-32
CrossRef4
Yoni Harel, Zipora Shechtman, Carolyn Cutrona. (2012) Exploration of Support Behavior in Counseling Groups With Counseling Trainees. The Journal for Specialists in Group Work1-16
CrossRef5
Darryl L. Pure. 2011. Single-Gender or Mixed-Gender Groups: Choosing a Perspective. , 381-396.
CrossRef6
Rafaela Hervatin, Stefanie Sperlich, Heike Koch-Giesselmann, Siegfried Geyer. (2011) Variability and stability of coping in women with breast cancer. Supportive Care in Cancer
CrossRef7
H. Faller. (2011) Evidenzbasierung psychoonkologischer Maßnahmen. Der Onkologe
CrossRef8
Perry M. Pauley, Mark T. Morman, Kory Floyd. (2011) Expressive Writing Improves Subjective Health Among Testicular Cancer Survivors: A Pilot Study. International Journal of Men's Health 10:3, 199-219
CrossRef9
Catherine E. Mosher, Katherine N. DuHamel, Joanne Lam, Maura Dickler, Yuelin Li, Mary Jane Massie, Larry Norton. (2011) Randomised trial of expressive writing for distressed metastatic breast cancer patients. Psychology & Health1-13
CrossRef10
J. Hefner, H. Csef. (2011) Psychoneuroimmunologie und Krebs. Der Onkologe 17:9, 839-850
CrossRef11
Anja Mehnert, Katharina Braack, Sigrun Vehling. (2011) Sinnorientierte Interventionen in der Psychoonkologie. Psychotherapeut 56:5, 394-399
CrossRef12
JiYeon Choi, Chien-Wen J. Kuo, Alla Sikorskii, Mei You, Dianxu Ren, Paula R. Sherwood, Charles W. Given, Barbara A. Given. (2011) Cognitive behavioral symptom management intervention in patients with cancer: survival analysis. Supportive Care in Cancer
CrossRef13
Catherine C. Classen, David Spiegel. 2011. Supportive-Expressive Group Psychotherapy. , 105-117.
CrossRef14
Ellen H. Boesen, Randi Karlsen, Jane Christensen, Birgitte Paaschburg, Dorte Nielsen, Iben Seier Bloch, Birgitte Christiansen, Kathrine Jacobsen, Christoffer Johansen. (2011) Psychosocial group intervention for patients with primary breast cancer: A randomised trial. European Journal of Cancer 47:9, 1363-1372
CrossRef15
Jeff Kendall, Kelly Glaze, Shari Oakland, Jeanice Hansen, Carla Parry. (2011) What do 1281 distress screeners tell us about cancer patients in a community cancer center?. Psycho-Oncology 20:6, 594-600
CrossRef16
Sophia K. Smith, James E. Herndon, H. Kim Lyerly, April Coan, Jane L. Wheeler, Tina Staley, Amy P. Abernethy. (2011) Correlates of quality of life-related outcomes in breast cancer patients participating in the Pathfinders pilot study. Psycho-Oncology 20:5, 559-564
CrossRef17
J. Lemieux, P. J. Goodwin, L. J. Bordeleau, S. Lauzier, V. Theberge. (2011) Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001-2009). JNCI Journal of the National Cancer Institute 103:3, 178-231
CrossRef18
Makoto Inoue, Fumiko Kaneko, Hitoshi Okamura. (2011) Evaluation of the Effectiveness of a Group Intervention Approach for Nurses Exposed to Violent Speech or Violence Caused by Patients: A Randomized Controlled Trial. ISRN Nursing 2011, 1-8
CrossRef19
Kuang-Yi Wen, Fiona McTavish, Gary Kreps, Meg Wise, David Gustafson. (2011) From Diagnosis to Death: A Case Study of Coping With Breast Cancer as Seen Through Online Discussion Group Messages. Journal of Computer-Mediated Communication 16:2, 331-361
CrossRef20
David W. Kissane, Tomer Levin, Sarah Hales, Christopher Lo, Gary Rodin. 2010. Psychotherapy for Depression in Cancer and Palliative Care. , 177-206.
CrossRef21
Ann Boonzaier, Annabel Pollard, Maria Ftanou, Jeremy W. Couper, Penelope Schofield, Linda Mileshkin, Michael Henderson. (2010) The practical challenges of recruitment and retention when providing psychotherapy to advanced breast cancer patients. Supportive Care in Cancer 18:12, 1605-1613
CrossRef22
Grace J. Yoo, Ellen G. Levine, Caryn Aviv, Cheryl Ewing, Alfred Au. (2010) Older women, breast cancer, and social support. Supportive Care in Cancer 18:12, 1521-1530
CrossRef23
Kerry A. Sherman, Greg Heard, Karen L. Cavanagh. (2010) Psychological effects and mediators of a group multi-component program for breast cancer survivors. Journal of Behavioral Medicine 33:5, 378-391
CrossRef24
J.-L. Machavoine. (2010) Groupes de malades en psycho-oncologie: éléments historiques, cliniques et pratiques. Psycho-Oncologie 4:3, 190-198
CrossRef25
Marilyn L. Kwan, Isaac Joshua Ergas, Carol P. Somkin, Charles P. Quesenberry, Alfred I. Neugut, Dawn L. Hershman, Jeanne Mandelblatt, Michael P. Pelayo, Allegra W. Timperi, Sunita Q. Miles, Lawrence H. Kushi. (2010) Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Research and Treatment 123:2, 507-524
CrossRef26
Ruvanee P. Vilhauer, Martha K. McClintock, Alicia K. Matthews. (2010) Online Support Groups for Women with Metastatic Breast Cancer: A Feasibility Pilot Study. Journal of Psychosocial Oncology 28:5, 560-586
CrossRef27
Lauren M. Walker, Theanna F. Bischoff, John W. Robinson. (2010) Supportive Expressive Group Therapy for Women with Advanced Ovarian Cancer. International Journal of Group Psychotherapy 60:3, 407-427
CrossRef28
Tal Weinberger, Anique Forrester, Dimitri Markov, Keira Chism, Elisabeth J.S. Kunkel. (2010) Women at a Dangerous Intersection: Diagnosis and Treatment of Depression and Related Disorders in Patients with Breast Cancer. Psychiatric Clinics of North America 33:2, 409-422
CrossRef29
Sandra A. Mitchell. (2010) Cancer-Related Fatigue: State of the Science. PM&R 2:5, 364-383
CrossRef30
Jason E. Owen, Laura Boxley, Michael S. Goldstein, Jennifer H. Lee, Nancy Breen, Julia H. Rowland. (2010) Use of Health-Related Online Support Groups: Population Data from the California Health Interview Survey Complementary and Alternative Medicine Study. Journal of Computer-Mediated Communication 15:3, 427-446
CrossRef31
Thom Reilly, Susan I. Woodruff, Laurie Smith, John D. Clapp, Jerry Cade. (2010) Unsafe Sex Among HIV Positive Individuals: Cross-Sectional and Prospective Predictors. Journal of Community Health 35:2, 115-123
CrossRef32
Grace J. Yoo, Caryn Aviv, Ellen G. Levine, Cheryl Ewing, Alfred Au. (2010) Emotion work: disclosing cancer. Supportive Care in Cancer 18:2, 205-215
CrossRef33
Isabelle Merckaert, Yves Libert, Sophie Messin, Mina Milani, Jean-Louis Slachmuylder, Darius Razavi. (2010) Cancer patients' desire for psychological support: prevalence and implications for screening patients' psychological needs. Psycho-Oncology 19:2, 141-149
CrossRef34
James C. Coyne, Howard Tennen. (2010) Positive Psychology in Cancer Care: Bad Science, Exaggerated Claims, and Unproven Medicine. Annals of Behavioral Medicine 39:1, 16-26
CrossRef35
Stefan Schneider, Anne Moyer, Sarah Knapp-Oliver, Stephanie Sohl, Dolores Cannella, Valerie Targhetta. (2010) Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. Journal of Behavioral Medicine 33:1, 1-14
CrossRef36
Yosuke Uchitomi. (2010) Psycho-oncology : An overview. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 122:2, 119-124
CrossRef37
Heidi Huddleston Cross, Patricia Hottenstein. (2010) Starting and Maintaining a Hospital‐Based Ostomy Support Group. Journal of Wound, Ostomy and Continence Nursing 37:4, 393-396
CrossRef38
Olivia S. Fu, Katherine D. Crew, Judith S. Jacobson, Heather Greenlee, Gary Yu, Julie Campbell, Yvette Ortiz, Dawn L. Hershman. (2009) Ethnicity and persistent symptom burden in breast cancer survivors. Journal of Cancer Survivorship 3:4, 241-250
CrossRef39
Jillian R. Satin, Wolfgang Linden, Melanie J. Phillips. (2009) Depression as a predictor of disease progression and mortality in cancer patients. Cancer 115:22, 5349-5361
CrossRef40
A. Vodermaier, W. Linden, C. Siu. (2009) Screening for Emotional Distress in Cancer Patients: A Systematic Review of Assessment Instruments. JNCI Journal of the National Cancer Institute 101:21, 1464-1488
CrossRef41
Alexandra Winzer, Annekatrin Hoppe, Jürgen Altenhoff, Christoph Kuwert, Uwe Koch, Holger Schulz. (2009) Interest in a psycho-educational group intervention among out-patients with malignant melanoma in relation to their need: which patients are likely to participate?. Psycho-Oncology 18:11, 1179-1188
CrossRef42
Lauren M. Walker, John W. Robinson. (2009) Qualitative Exploration of Healthcare Relationships Following Delayed Diagnosis of Ovarian Cancer and Subsequent Participation in Supportive-Expressive Group Therapy. Oncology Nursing Forum 36:6, E310-E316
CrossRef43
Julia H. Rowland, Beth E. Meyerowitz, Catherine M. Crespi, Beth Leedham, Katherine Desmond, Thomas R. Belin, Patricia A. Ganz. (2009) Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. Breast Cancer Research and Treatment 118:1, 99-111
CrossRef44
Dina Goldstein, Lisa M. Frantsve. (2009) Group Psychotherapy for Chronic Illness: Clinical Applications of Selected Empirical Studies. International Journal of Group Psychotherapy 59:4, 577-583
CrossRef45
Sheldon Cohen, Denise Janicki-Deverts. (2009) Can We Improve Our Physical Health by Altering Our Social Networks?. Perspectives on Psychological Science 4:4, 375-378
CrossRef46
D. MANOS, J. SEBASTIÁN, N. MATEOS, M.J. BUENO. (2009) Results of a multi-componential psychosocial intervention programme for women with early-stage breast cancer in Spain: quality of life and mental adjustment. European Journal of Cancer Care 18:3, 295-305
CrossRef47
Morton A. Lieberman, Andrew Winzelberg. (2009) The relationship between religious expression and outcomes in online support groups: A partial replication. Computers in Human Behavior 25:3, 690-694
CrossRef48
Scott A. Irwin. (2009) A call for simple and rational palliative medicine psychotropic prescribing guidelines: Response to Barnhorst et al. ( Palliative & Supportive Care, Volume 6, Number 1, 2008). Palliative and Supportive Care 7:01, 3
CrossRef49
Sandra C. Naaman, Karam Radwan, Dean Fergusson, Susan Johnson. (2009) Status of Psychological Trials in Breast Cancer Patients: A Report of Three Meta-Analyses. Psychiatry: Interpersonal & Biological Processes 72:1, 50-69
CrossRef50
Tanja Zimmermann, Nina Heinrichs, Donald H. Baucom. (2009) Is a Meta-Analysis Following Common Meta-Analytical Procedures Going Awry? A Response to Coyne, Thombs, and Hagedoorn. Annals of Behavioral Medicine 37:1, 97-100
CrossRef51
James C. Coyne, Brett D. Thombs, Mariet Hagedoorn. (2009) A Meta-Analysis of Psychosocial Interventions for Cancer Patients Gone Awry. Annals of Behavioral Medicine 37:1, 94-96
CrossRef52
Martine Margaretha Goedendorp, Marieke FM Gielissen, Constantijn AHHVM Verhagen, Gijs Bleijenberg, Martine Margaretha Goedendorp. 2009. Psychosocial interventions for reducing fatigue during cancer treatment in adults. .
CrossRef53
David Kissane. (2009) Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psycho-Oncology 18:1, 1-5
CrossRef54
Barbara L. Andersen, Hae-Chung Yang, William B. Farrar, Deanna M. Golden-Kreutz, Charles F. Emery, Lisa M. Thornton, Donn C. Young, William E. Carson. (2008) Psychologic intervention improves survival for breast cancer patients. Cancer 113:12, 3450-3458
CrossRef55
Aude Caplette-Gingras, Josée Savard. (2008) Depression in women with metastatic breast cancer: A review of the literature. Palliative and Supportive Care 6:04, 377
CrossRef56
Michael Robert Dennis, Adrianne Kunkel, Joann Keyton. (2008) Problematic Integration Theory, Appraisal Theory, and the Bosom Buddies Breast Cancer Support Group. Journal of Applied Communication Research 36:4, 415-436
CrossRef57
Gary L. Kreps, Rama Sivaram. (2008) Strategic health communication across the continuum of breast cancer care in limited-resource countries. Cancer 113:S8, 2331-2337
CrossRef58
Jessica Daniels, David W Kissane. (2008) Psychosocial interventions for cancer patients. Current Opinion in Internal Medicine 7:5, 493-497
CrossRef59
Chun-Ju Liu, Ping-Chuan Hsiung, King-Jen Chang, Yu-Fen Liu, Kuo-Chang Wang, Fei-Hsiu Hsiao, Siu-Man Ng, Cecilia LW Chan. (2008) A study on the efficacy of body-mind-spirit group therapy for patients with breast cancer. Journal of Clinical Nursing 17:19, 2539-2549
CrossRef60
Ellen H Boesen, Christoffer Johansen. (2008) Impact of psychotherapy on cancer survival: time to move on?. Current Opinion in Internal Medicine 7:5, 498-503
CrossRef61
Ruvanee P. Vilhauer. (2008) A qualitative study of the experiences of women with metastatic breast cancer. Palliative & Supportive Care 6:03,
CrossRef62
M LIEBERMAN. (2008) Effects of disease and leader type on moderators in online support groups. Computers in Human Behavior 24:5, 2446-2455
CrossRef63
James S. Gordon. (2008) Mind-Body Medicine and Cancer. Hematology/Oncology Clinics of North America 22:4, 683-708
CrossRef64
Kirsten P. Smith, Nicholas A. Christakis. (2008) Social Networks and Health. Annual Review of Sociology 34:1, 405-429
CrossRef65
Takeo Takahashi, Mikito Hondo, Keiichiro Nishimura, Akira Kitani, Takafumi Yamano, Hisami Yanagita, Hisato Osada, Munefumi Shinbo, Norinari Honda. (2008) Evaluation of quality of life and psychological response in cancer patients treated with radiotherapy. Radiation Medicine 26:7, 396-401
CrossRef66
Kathrin Strasser-Weippl, Heinz Ludwig. (2008) Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma. European Journal of Haematology
CrossRef67
Adrian GK Edwards, Nicholas Hulbert-Williams, Richard D Neal, Adrian GK Edwards. 2008. Psychological interventions for women with metastatic breast cancer. .
CrossRef68
M. Reich, A. Lesur, C. Perdrizet-Chevallier. (2008) Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Research and Treatment 110:1, 9-17
CrossRef69
Ellen H Boesen, Christoffer Johansen. (2008) Impact of psychotherapy on cancer survival: time to move on?. Current Opinion in Oncology 20:4, 372-377
CrossRef70
Jessica Daniels, David W Kissane. (2008) Psychosocial interventions for cancer patients. Current Opinion in Oncology 20:4, 367-371
CrossRef71
Derek R. Hopko, John L. Bell, Maria Armento, Sarah Robertson, Christen Mullane, Nicole Wolf, Carl W. Lejuez. (2008) Cognitive-Behavior Therapy for Depressed Cancer Patients in a Medical Care Setting. Behavior Therapy 39:2, 126-136
CrossRef72
Daniel A. Monti, Meryl Sufian, Caroline Peterson. (2008) Potential role of mind-body therapies in cancer survivorship. Cancer 112:S11, 2607-2616
CrossRef73
Catherine C. Classen, Helena C. Kraemer, Christine Blasey, Janine Giese-Davis, Cheryl Koopman, Oxana Gronskaya Palesh, Ami Atkinson, Sue DiMiceli, Gail Stonisch-Riggs, Joan Westendorp, Gary R. Morrow, David Spiegel. (2008) Supportive–expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial. Psycho-Oncology 17:5, 438-447
CrossRef74
Tatsuo Akechi, Toru Okuyama, Joji Onishi, Tatsuya Morita, Toshi A Furukawa, Tatsuo Akechi. 2008. Psychotherapy for depression among incurable cancer patients. .
CrossRef75
Elizabeth Chapman, Judith Whale, Annette Landy, David Hughes, Margaret Saunders. (2008) Clinical evaluation of the Mood and Symptom Questionnaire (MSQ) in a day therapy unit in a palliative support centre in the United Kingdom. Palliative & Supportive Care 6:01,
CrossRef76
James J. Strain, Albert Diefenbacher. (2008) The adjustment disorders: the conundrums of the diagnoses. Comprehensive Psychiatry 49:2, 121-130
CrossRef77
Mary O'Brien, Jill Harris, Robert King, Tom O'Brien. (2008) Supportive-expressive group therapy for women with metastatic breast cancer: Improving access for Australian women through use of teleconference. Counselling and Psychotherapy Research 8:1, 28-35
CrossRef78
Ilaria Spoletini, Walter Gianni, Lazzaro Repetto, Pietro Bria, Carlo Caltagirone, Paola Bossù, Gianfranco Spalletta. (2008) Depression and cancer: An unexplored and unresolved emergent issue in elderly patients. Critical Reviews in Oncology/Hematology 65:2, 143-155
CrossRef79
Steven Greer. (2008) CBT for emotional distress of people with cancer: some personal observations. Psycho-Oncology 17:2, 170-173
CrossRef80
Suzanne C. Lechner, Brenda L. Stoelb, Michael H. Antoni. 2008. Group-Based Therapies for Benefit Finding in Cancer. , 207-231.
CrossRef81
Matthew J. Cordova. 2008. Facilitating Posttraumatic Growth Following Cancer. , 183-205.
CrossRef82
Itay Greenspan, Femida Handy. 2008. From discovery to recovery and beyond: The role of voluntary health sector organizations in the lives of women with breast cancer. , 151-176.
CrossRef83
Jan Marco Leimeister, Karin Schweizer, Stefanie Leimeister, Helmut Krcmar. (2008) Do virtual communities matter for the social support of patients?: Antecedents and effects of virtual relationships in online communities. Information Technology & People 21:4, 350-374
CrossRef84
J GIESEDAVIS, A CONRAD, B NOURIANI, D SPIEGEL. (2008) Exploring emotion-regulation and autonomic physiology in metastatic breast cancer patients: Repression, suppression, and restraint of hostility. Personality and Individual Differences 44:1, 226-237
CrossRef85
S. Marchal, D. Razavi. 2008. Deuil, complications et traitements. , 417-430.
CrossRef86
D. Razavi, N. Delvaux, S. Marchal, A. Moucheux. 2008. Interventions psychologiques. , 297-327.
CrossRef87
E. Boesen, S. Boesen, S. Christensen, C. Johansen. (2007) Comparison of Participants and Non-Participants in a Randomized Psychosocial Intervention Study Among Patients With Malignant Melanoma. Psychosomatics 48:6, 510-516
CrossRef88
Gil Bar-Sela, Lily Atid, Sara Danos, Naomi Gabay, Ron Epelbaum. (2007) Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapy. Psycho-Oncology 16:11, 980-984
CrossRef89
James C. Coyne, Laura J. Hanisch, Steven C. Palmer. (2007) Psychotherapy does not promote survival (Kissaneet al., 2007): now what?. Psycho-Oncology 16:11, 1050-1052
CrossRef90
C. Schneider. (2007) Psychoonkologische Aspekte bei gynäkologischen Malignomen. Der Gynäkologe 40:11, 865-871
CrossRef91
Linda E. Carlson, Michael Speca, Peter Faris, Kamala D. Patel. (2007) One year pre–post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain, Behavior, and Immunity 21:8, 1038-1049
CrossRef92
Michael Miovic, Susan Block. (2007) Psychiatric disorders in advanced cancer. Cancer 110:8, 1665-1676
CrossRef93
Petra J. Vos, Adriaan P. Visser, Bert Garssen, Hugo J. Duivenvoorden, Hanneke C. J. M. de Haes. (2007) Effectiveness of Group Psychotherapy Compared to Social Support Groups in Patients with Primary, Non-Metastatic Breast Cancer. Journal of Psychosocial Oncology 25:4, 37-60
CrossRef94
Tanja Zimmermann, Nina Heinrichs, Donald H. Baucom. (2007) “Does one size fit all?” moderators in psychosocial interventions for breast cancer patients: A meta-analysis. Annals of Behavioral Medicine 34:3, 225-239
CrossRef95
Barbara L. Andersen, William B. Farrar, Deanna Golden-Kreutz, Charles F. Emery, Ronald Glaser, Timothy Crespin, William E. Carson. (2007) Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain, Behavior, and Immunity 21:7, 953-961
CrossRef96
H. Kumano, I. Ida, A. Oshima, K. Takahashi, N. Yuuki, M. Amanuma, N. Oriuchi, K. Endo, H. Matsuda, M. Mikuni. (2007) Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients –A preliminary PET study. Journal of Psychiatric Research 41:7, 591-599
CrossRef97
Anna M. Nápoles-Springer, Carmen Ortíz, Helen O’Brien, Marynieves Díaz-Méndez, Eliseo J. Pérez-Stable. (2007) Use of cancer support groups among Latina breast cancer survivors. Journal of Cancer Survivorship 1:3, 193-204
CrossRef98
David Spiegel, Lisa D. Butler, Janine Giese-Davis, Cheryl Koopman, Elaine Miller, Sue DiMiceli, Catherine C. Classen, Patricia Fobair, Robert W. Carlson, Helena C. Kraemer. (2007) Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer. Cancer 110:5, 1130-1138
CrossRef99
Mogens Groenvold, Morten Aagaard Petersen, Ellen Idler, Jakob Bue Bjorner, Peter M. Fayers, Henning T. Mouridsen. (2007) Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Research and Treatment 105:2, 209-219
CrossRef100
Daniel L. Boutin. (2007) Effectiveness of Cognitive Behavioral and Supportive-Expressive Group Therapy for Women Diagnosed with Breast Cancer: A Review of the Literature. The Journal for Specialists in Group Work 32:3, 267-284
CrossRef101
Joanne E. Stephen, Michelle Rahn, Marja Verhoef, Anne Leis. (2007) What is the state of the evidence on the mind–cancer survival question, and where do we go from here? A point of view. Supportive Care in Cancer 15:8, 923-930
CrossRef102
A. Fuchsia Howard, Joan L. Bottorff, Lynda G. Balneaves, Sukhdev K. Grewal. (2007) Punjabi Immigrant Women’s Breast Cancer Stories. Journal of Immigrant and Minority Health 9:4, 269-279
CrossRef103
Julie Lemieux, Dorcas E. Beaton, Sheilah Hogg-Johnson, Louise J. Bordeleau, Jon Hunter, Pamela J. Goodwin. (2007) Responsiveness to change to change due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer. Quality of Life Research 16:6, 1007-1017
CrossRef104
Cindy L. Carmack Taylor, James Kulik, Hoda Badr, Murray Smith, Karen Basen-Engquist, Frank Penedo, Ellen R. Gritz. (2007) A social comparison theory analysis of group composition and efficacy of cancer support group programs. Social Science & Medicine 65:2, 262-273
CrossRef105
Martin R Stockler, Rachel O'Connell, Anna K Nowak, David Goldstein, Jane Turner, Nicholas RC Wilcken, David Wyld, Ehtesham A Abdi, Amanda Glasgow, Philip J Beale, Michael Jefford, Haryana Dhillon, Stephane Heritier, Candace Carter, Ian B Hickie, R John Simes. (2007) Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. The Lancet Oncology 8:7, 603-612
CrossRef106
K. Zulkowski, G. Spahn, C. Schleußner, D. Jaenichen, K. Höffken. (2007) Gruppeninterventionsprogramme in der Onkologie. Der Onkologe 13:6, 520-527
CrossRef107
A. Gagliardi, F. C. Wright, M. L. Quan, D. McCready. (2007) Evaluating the organization and delivery of breast cancer services: use of performance measures to identify knowledge gaps. Breast Cancer Research and Treatment 103:2, 131-148
CrossRef108
Benjamin H. Gottlieb, Elizabeth D. Wachala. (2007) Cancer support groups: a critical review of empirical studies. Psycho-Oncology 16:5, 379-400
CrossRef109
Neeraj K. Arora, Lila J. Finney Rutten, David H. Gustafson, Richard Moser, Robert P. Hawkins. (2007) Perceived helpfulness and impact of social support provided by family, friends, and health care providers to women newly diagnosed with breast cancer. Psycho-Oncology 16:5, 474-486
CrossRef110
Julie Lemieux, Dorcas E. Beaton, Sheilah Hogg-Johnson, Louise J. Bordeleau, Pamela J. Goodwin. (2007) Three methods for minimally important difference: no relationship was found with the net proportion of patients improving. Journal of Clinical Epidemiology 60:5, 448-455
CrossRef111
Jody M. Jackson, Sharon J. Rolnick, Steve S. Coughlin, Christine Neslund-Dudas, Mark C. Hornbrook, Jeanne Darbinian, Donald J. Bachman, Lisa J. Herrinton. (2007) Social support among women who died of ovarian cancer. Supportive Care in Cancer 15:5, 547-556
CrossRef112
Neeraj K. Arora, Ann S. Hamilton, Arnold L. Potosky, Julia H. Rowland, Noreen M. Aziz, Keith M. Bellizzi, Carrie N. Klabunde, Wendy McLaughlin, Jennifer Stevens. (2007) Population-based survivorship research using cancer registries: a study of non-Hodgkin’s Lymphoma survivors. Journal of Cancer Survivorship: Research and Practice 1:1, 49-63
CrossRef113
David W. Kissane, Brenda Grabsch, David M. Clarke, Graeme C. Smith, Anthony W. Love, Sidney Bloch, Raymond D. Snyder, Yuelin Li. (2007) Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psycho-Oncology 16:4, 277-286
CrossRef114
James W. Carson, Kimberly M. Carson, Laura S. Porter, Francis J. Keefe, Heather Shaw, Julie M. Miller. (2007) Yoga for Women with Metastatic Breast Cancer: Results from a Pilot Study. Journal of Pain and Symptom Management 33:3, 331-341
CrossRef115
GERD INGER RINGDAL, KRISTEN RINGDAL, MARIT S. JORDHØY, STEIN KAASA. (2007) Does social support from family and friends work as a buffer against reactions to stressful life events such as terminal cancer?. Palliative & Supportive Care 5:01,
CrossRef116
Stephen R. Connor, Bruce Pyenson, Kathryn Fitch, Carol Spence, Kosuke Iwasaki. (2007) Comparing Hospice and Nonhospice Patient Survival Among Patients Who Die Within a Three-Year Window. Journal of Pain and Symptom Management 33:3, 238-246
CrossRef117
Linda D. Cameron, Roger J. Booth, Melanie Schlatter, Danute Ziginskas, John E. Harman. (2007) Changes in emotion regulation and psychological adjustment following use of a group psychosocial support program for women recently diagnosed with breast cancer. Psycho-Oncology 16:3, 171-180
CrossRef118
Sue P. Heiney, Janis McWayne, Laurie Ford, Cindy Carter. (2006) Measurement in Group Interventions for Women with Breast Cancer. Journal of Psychosocial Oncology 24:4, 89-106
CrossRef119
Edzard Ernst, Katja Schmidt, Michael Baum. (2006) Complementary/Alternative Therapies for the Treatment of Breast Cancer. A Systematic Review of Randomized Clinical Trials and a Critique of Current Terminology. The Breast Journal 12:6, 526-530
CrossRef120
Julie Lemieux, Adam Topp, Heather Chappell, Marguerite Ennis, Pamela J. Goodwin. (2006) Economic Analysis of Psychosocial Group Therapy in Women with Metastatic Breast Cancer. Breast Cancer Research and Treatment 100:2, 183-190
CrossRef121
James C. Coyne, Stephen J. Lepore, Steven C. Palmer. (2006) Efficacy of psychosocial interventions in cancer care: Evidence is weaker than it first looks. Annals of Behavioral Medicine 32:2, 104-110
CrossRef122
Sandra A. Mitchell, Ann M. Berger. (2006) Cancer-Related Fatigue. The Cancer Journal 12:5, 374-387
CrossRef123
JOSÉE SAVARD, SÉBASTIEN SIMARD, ISABELLE GIGUÈRE, HANS IVERS, CHARLES M. MORIN, ELIZABETH MAUNSELL, PIERRE GAGNON, JEAN ROBERT, DANIÈLE MARCEAU. (2006) Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: Psychological and immunological effects. Palliative & Supportive Care 4:03,
CrossRef124
D. J. L. Joske, A. Rao, L. Kristjanson. (2006) Critical review of complementary therapies in haemato-oncology. Internal Medicine Journal 36:9, 579-586
CrossRef125
Susan D. Block. (2006) Psychological Issues in End-of-Life Care. Journal of Palliative Medicine 9:3, 751-772
CrossRef126
T. P. Beresford, J. Alfers, L. Mangum, L. Clapp, B. Martin. (2006) Cancer Survival Probability as a Function of Ego Defense (Adaptive) Mechanisms Versus Depressive Symptoms. Psychosomatics 47:3, 247-253
CrossRef127
Daniel A. Monti, Caroline Peterson, Elisabeth J. Shakin Kunkel, Walter W. Hauck, Edward Pequignot, Lora Rhodes, George C. Brainard. (2006) A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancer. Psycho-Oncology 15:5, 363-373
CrossRef128
Kathryn M. Kash, Rajnish Mago, Shannon Duffany, Elisabeth J. S. Kunkel. (2006) Psycho-oncology: Review and update. Current Psychiatry Reports 8:3, 246-252
CrossRef129
Donna Pauler Ankerst, Jutta Engel. (2006) Status of quality of life in breast cancer research before, during and beyond treatment. Expert Review of Pharmacoeconomics & Outcomes Research 6:2, 207-214
CrossRef130
Vicki Brower. (2006) Mind–body research moves towards the mainstream. EMBO reports 7:4, 358-361
CrossRef131
Gerald M. Devins, Andrea Bezjak, Kenneth Mah, D. Andrew Loblaw, Andrew P. Gotowiec. (2006) Context moderates illness-induced lifestyle disruptions across life domains: a test of the illness intrusiveness theoretical framework in six common cancers. Psycho-Oncology 15:3, 221-233
CrossRef132
Michael H. Antoni, Susan K. Lutgendorf, Steven W. Cole, Firdaus S. Dhabhar, Sandra E. Sephton, Paige Green McDonald, Michael Stefanek, Anil K. Sood. (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nature Reviews Cancer 6:3, 240-248
CrossRef133
Barret Michalec. (2006) Exploring the Multidimensional Benefits of Breast Cancer Support Groups. Journal of Psychosocial Oncology 23:2-3, 159-179
CrossRef134
S Williams, J Dale. (2006) The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. British Journal of Cancer 94:3, 372-390
CrossRef135
Morton A. Lieberman, Benjamin A. Goldstein. (2006) Not all negative emotions are equal: the role of emotional expression in online support groups for women with breast cancer. Psycho-Oncology 15:2, 160-168
CrossRef136
Paul Brown, Matthew M. Clark, Pamela Atherton, Mashele Huschka, Jeff A. Sloan, Gail Gamble, Jean Girardi, Marlene H. Frost, Kate Piderman, Teresa A. Rummans. (2006) Will Improvement in Quality of Life (QOL) Impact Fatigue in Patients Receiving Radiation Therapy for Advanced Cancer?. American Journal of Clinical Oncology 29:1, 52-58
CrossRef137
Marina Vamos. (2006) Psychotherapy in the medically ill: a commentary. Australian and New Zealand Journal of Psychiatry 40:4, 295-309
CrossRef138
A. Remmel. (2006) Stress und Immunität. Der Onkologe 12:1, 7-17
CrossRef139
Vicki S. Helgeson, Stephen J. Lepore, David T. Eton. (2006) Moderators of the Benefits of Psychoeducational Interventions for Men With Prostate Cancer.. Health Psychology 25:3, 348-354
CrossRef140
F. Vitinius, D. Rohde. (2006) Uropsychoonkologie. Der Onkologe 12:1, 64-68
CrossRef141
Carissa A. Low, Annette L. Stanton, Sharon Danoff-Burg. (2006) Expressive disclosure and benefit finding among breast cancer patients: Mechanisms for positive health effects.. Health Psychology 25:2, 181-189
CrossRef142
Charles S. Carver. (2005) Enhancing adaptation during treatment and the role of individual differences. Cancer 104:S11, 2602-2607
CrossRef143
Pamela J. Goodwin. (2005) Support groups in advanced breast cancer. Cancer 104:S11, 2596-2601
CrossRef144
David H. Gustafson, Fiona M. McTavish, William Stengle, Denise Ballard, Robert Hawkins, Bret R. Shaw, Ellen Jones, Karen Julèsberg, Helene McDowell, Wei Chih Chen, Kanittha Volrathongchai, Gina Landucci. (2005) Use and Impact of eHealth System by Low-income Women With Breast Cancer. Journal of Health Communication 10:sup1, 195-218
CrossRef145
Thomas R. Large. (2005) Resistance in Long–Term Cancer Support Groups. International Journal of Group Psychotherapy 55:4, 551-573
CrossRef146
Dwight L. Evans, Dennis S. Charney, Lydia Lewis, Robert N. Golden, Jack M. Gorman, K. Ranga Rama Krishnan, Charles B. Nemeroff, J. Douglas Bremner, Robert M. Carney, James C. Coyne, Mahlon R. Delong, Nancy Frasure-Smith, Alexander H. Glassman, Philip W. Gold, Igor Grant, Lisa Gwyther, Gail Ironson, Robert L. Johnson, Andres M. Kanner, Wayne J. Katon, Peter G. Kaufmann, Francis J. Keefe, Terence Ketter, Thomas P. Laughren, Jane Leserman, Constantine G. Lyketsos, William M. McDonald, Bruce S. McEwen, Andrew H. Miller, Dominique Musselman, Christopher O’Connor, John M. Petitto, Bruce G. Pollock, Robert G. Robinson, Steven P. Roose, Julia Rowland, Yvette Sheline, David S. Sheps, Gregory Simon, David Spiegel, Albert Stunkard, Trey Sunderland, Paul Tibbits, William J. Valvo. (2005) Mood Disorders in the Medically Ill: Scientific Review and Recommendations. Biological Psychiatry 58:3, 175-189
CrossRef147
Linda K Goodwin, Sang Min Lee, Ana I. Puig, Peter A. D. Sherrard. (2005) Guided Imagery and Relaxation for Women with Early Stage Breast Cancer. Journal of Creativity in Mental Health 1:2, 53-66
CrossRef148
Masami Chujo, Ichiro Mikami, Shigemitsu Takashima, Toshiaki Saeki, Shozo Ohsumi, Kenjiro Aogi, Hitoshi Okamura. (2005) A feasibility study of psychosocial group intervention for breast cancer patients with first recurrence. Supportive Care in Cancer 13:7, 503-514
CrossRef149
Branka Aukst-Margetić, Miro Jakovljević, Branimir Margetić, Mirjana Bišćan, Mirko Šamija. (2005) Religiosity, depression and pain in patients with breast cancer. General Hospital Psychiatry 27:4, 250-255
CrossRef150
Laurel Northouse, Trace Kershaw, Darlene Mood, Ann Schafenacker. (2005) Effects of a family intervention on the quality of life of women with recurrent breast cancer and their family caregivers. Psycho-Oncology 14:6, 478-491
CrossRef151
Augusto Caraceni, Cinzia Brunelli, Cinzia Martini, Ernesto Zecca, Franco De Conno. (2005) Cancer Pain Assessment in Clinical Trials. A Review of the Literature (1999–2002). Journal of Pain and Symptom Management 29:5, 507-519
CrossRef152
Tomasz R. Okon. (2005) Spiritual, Religious, and Existential Aspects of Palliative Care. Journal of Palliative Medicine 8:2, 392-414
CrossRef153
Kathryn M. Kash, Rajnish Mago, Elisabeth J.S. Kunkel. (2005) Psychosocial oncology: Supportive care for the cancer patient. Seminars in Oncology 32:2, 211-218
CrossRef154
Samir S. Patel, Rolf A. Peterson, Paul L. Kimmel. (2005) PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: The Impact of Social Support on End-Stage Renal Disease. Seminars in Dialysis 18:2, 98-102
CrossRef155
Bronwen Beacham, Christine Hill, Fiona McDermott, Mary O'Brien, Jane Turner. (2005) Therapy with women with metastatic breast cancer. Australasian Psychiatry 13:1, 50-53
CrossRef156
Hosanna Soler-Vila, Stanislav V Kasl, Beth A Jones. (2005) Cancer-specific beliefs and survival: A population-based study of African-American and White breast cancer patients. Cancer Causes & Control 16:2, 105-114
CrossRef157
G ALPERS, A WINZELBERG, C CLASSEN, H ROBERTS, P DEV, C KOOPMAN, C BARRTAYLOR. (2005) Evaluation of computerized text analysis in an Internet breast cancer support group. Computers in Human Behavior 21:2, 361-376
CrossRef158
Deanna M. Golden-Kreutz, Lisa M. Thornton, Sharla Wells-Di Gregorio, Georita M. Frierson, Heather S. Jim, Kristen M. Carpenter, Rebecca A. Shelby, Barbara L. Andersen. (2005) Traumatic Stress, Perceived Global Stress, and Life Events: Prospectively Predicting Quality of Life in Breast Cancer Patients.. Health Psychology 24:3, 288-296
CrossRef159
Kathryn L. Herbst-Damm, James A. Kulik. (2005) Volunteer Support, Marital Status, and the Survival Times of Terminally Ill Patients.. Health Psychology 24:2, 225-229
CrossRef160
Tracey A. Revenson, Julie R. Pranikoff. (2005) A Contextual Approach to Treatment Decision Making Among Breast Cancer Survivors.. Health Psychology 24:4, Suppl, S93-S98
CrossRef161
ODDGEIR FRIBORG. (2005) BREAST CANCER: A MANUAL FOR A PROPOSED GROUP TREATMENT INTEGRATING EVIDENCE BASED RESILIENCE FACTORS. Psychological Reports 97:5, 77
CrossRef162
D. R. Hopko, J. L. Bell, M. E. A. Armento, M. K. Hunt, C. W. Lejuez. (2005) Behavior Therapy for Depressed Cancer Patients in Primary Care.. Psychotherapy: Theory, Research, Practice, Training 42:2, 236-243
CrossRef163
D. Lesbros-Pantoflickova, P. Michetti, M. Fried, C. Beglinger, A. L. Blum. (2004) Meta-analysis: the treatment of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 20:11-12, 1253-1269
CrossRef164
Katrin Reuter, Simone Raugust, J
rgen Bengel, Martin H
CrossRef165
OAKLEY RAY. (2004) The Revolutionary Health Science of Psychoendoneuroimmunology: A New Paradigm for Understanding Health and Treating Illness. Annals of the New York Academy of Sciences 1032:1, 35-51
CrossRef166
Mary Jane Esplen, Jon Hunter, Molyn Leszcz, Ellen Warner, Steven Narod, Kelly Metcalfe, Gord Glendon, Kate Butler, Alexander Liede, Mary Anne Young, Stephanie Kieffer, Lisa DiProspero, Ellen Irwin, Jiahui Wong. (2004) A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer 101:10, 2327-2340
CrossRef167
David W. Kissane, Brenda Grabsch, David M. Clarke, George Christie, Diane Clifton, Stan Gold, Christine Hill, Ann Morgan, Fiona McDermott, Graeme C. Smith. (2004) Supportive-expressive group therapy: The transformation of existential ambivalence into creative living while enhancing adherence to anti-cancer therapies. Psycho-Oncology 13:11, 755-768
CrossRef168
Lone Ross, Birthe Lykke Thomsen, Ellen Helle Boesen, Christoffer Johansen. (2004) In a randomized controlled trial, missing data led to biased results regarding anxiety. Journal of Clinical Epidemiology 57:11, 1131-1137
CrossRef169
Rainbow T.H. Ho, Cecilia L.W. Chan, Samuel M.Y. Ho. (2004) Emotional control in Chinese female cancer survivors. Psycho-Oncology 13:11, 808-817
CrossRef170
Edna Maria Vissoci Reiche, Sandra Odebrecht Vargas Nunes, Helena Kaminami Morimoto. (2004) Stress, depression, the immune system, and cancer. The Lancet Oncology 5:10, 617-625
CrossRef171
H.Sharon Campbell, Marie Rose Phaneuf, Karen Deane. (2004) Cancer peer support programs—do they work?. Patient Education and Counseling 55:1, 3-15
CrossRef172
Molyn Leszcz, Allen Sherman, Julie Mosier, Gary M. Burlingame, Trish Cleary, Kathleen Hubbs Ulman, Stephanie Simonton, Umaira Latif, Bernhard Strauss, Lara Hazelton. (2004) Group Interventions for Patients with Cancer and HIV Disease: Part IV. Clinical and Policy Recommendations. International Journal of Group Psychotherapy 54:4, 539-556
CrossRef173
Bruce Pyenson, Stephen Connor, Kathryn Fitch, Barry Kinzbrunner. (2004) Medicare cost in matched hospice and non-hospice cohorts. Journal of Pain and Symptom Management 28:3, 200-210
CrossRef174
R J Uitterhoeve, M Vernooy, M Litjens, K Potting, J Bensing, P De Mulder, T van Achterberg. (2004) Psychosocial interventions for patients with advanced cancer – a systematic review of the literature. British Journal of Cancer
CrossRef175
Jim Lemon, Sarah Edelman, Antony D. Kidman. (2004) Perceptions of the “Mind-Cancer” Relationship Among the Public, Cancer Patients, and Oncologists. Journal of Psychosocial Oncology 21:4, 43-58
CrossRef176
Allen C. Sherman, Julie Mosier, Molyn Leszcz, Gary M. Burlingame, Kathleen Hubbs Ulman, Trish Cleary, Stephanie Simonton, Umaira Latif, Lara Hazelton, Bernhard Strauss. (2004) Group Interventions for Patients with Cancer and HIV Disease: Part III. Moderating Variables and Mechanisms of Action. International Journal of Group Psychotherapy 54:3, 347-387
CrossRef177
Steven C Palmer, James C Coyne. (2004) Examining the evidence that psychotherapy improves the survival of cancer patients. Biological Psychiatry 56:1, 61-62
CrossRef178
Linda Zeigler, Patricia A Smith, Jacqueline Fawcett. (2004) Breast cancer: evaluation of the Common Journey Breast Cancer Support Group. Journal of Clinical Nursing 13:4, 467-478
CrossRef179
AGK Edwards, N Hulbert-Williams, RD Neal, Adrian Edwards. 2004. Psychological interventions for women with metastatic breast cancer. .
CrossRef180
Allen C. Sherman, Molyn Leszcz, Julie Mosier, Gary M. Burlingame, Trish Cleary, Kathleen Hubbs Ulman, Stephanie Simonton, Umaira Latif, Bernhard Strauss, Lara Hazelton. (2004) Group Interventions for Patients with Cancer and HIV Disease: Part II. Effects on Immune, Endocrine, and Disease Outcomes at Different Phases of Illness. International Journal of Group Psychotherapy 54:2, 203-233
CrossRef181
Sheldon Cohen. (2004) Social Relationships and Health.. American Psychologist 59:8, 676-684
CrossRef182
Allen C. Sherman, Julie Mosier, Molyn Leszcz, Gary M. Burlingame, Kathleen H. Ulman, Trish Cleary, Stephanie Simonton, Umaira Latif, Lara Hazelton, Bernhard Strauss. (2004) Group Interventions for Patients with Cancer and HIV Disease: Part I: Effects on Psychosocial and Functional Outcomes at Different Phases of Illness. International Journal of Group Psychotherapy 54:1, 29-82
CrossRef183
(2004) COMMENTARIES on "Posttraumatic Growth: Conceptual Foundations and Empirical Evidence". Psychological Inquiry 15:1, 19-92
CrossRef184
Oakley Ray. (2004) How the Mind Hurts and Heals the Body.. American Psychologist 59:1, 29-40
CrossRef185
Sue P. Heiney, Janis McWayne, Thomas G. Hurley, Lawrence S. Lamb, Lisa H. Bryant, William Butler, Kamar Godder. (2003) Efficacy of Therapeutic Group by Telephone for Women With Breast Cancer. Cancer Nursing 26:6, 439???447
CrossRef186
Alice B Kornblith, Jennifer Ligibel. (2003) Psychosocial and sexual functioning of survivors of breast cancer. Seminars in Oncology 30:6, 799-813
CrossRef187
Ronald C. Kessler, Johan Ormel, Olga Demler, Paul E. Stang. (2003) Comorbid Mental Disorders Account for the Role Impairment of Commonly Occurring Chronic Physical Disorders: Results From the National Comorbidity Survey. Journal of Occupational and Environmental Medicine 45:12, 1257-1266
CrossRef188
M. M. Clark, J. M. Bostwick, T. A. Rummans. (2003) Group and Individual Treatment Strategies for Distress in Cancer Patients. Mayo Clinic Proceedings 78:12, 1538-1543
CrossRef189
Gerald M Devins, David C Mendelssohn, Paul E Barré, Yitzchak M Binik. (2003) Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease. American Journal of Kidney Diseases 42:4, 693-703
CrossRef190
ZEINA NAHLEH, IMAD A. TABBARA. (2003) Complementary and alternative medicine in breast cancer patients. Palliative & Supportive Care 1:03,
CrossRef191
David W. Kissane, Sidney Bloch, Graeme C. Smith, Patricia Miach, David M. Clarke, Jillian Ikin, Anthony Love, Nadia Ranieri, Dean McKenzie. (2003) Cognitive-existential group psychotherapy for women with primary breast cancer: A randomised controlled trial. Psycho-Oncology 12:6, 532-546
CrossRef192
E SHAKINKUNKEL, E CHEN. (2003) Psychiatric aspects of women with breast cancer. Psychiatric Clinics of North America 26:3, 713-724
CrossRef193
A. Schattner. (2003) The emotional dimension and the biological paradigm of illness: time for a change. QJM 96:9, 617-621
CrossRef194
David Spiegel, Janine Giese-Davis. (2003) Depression and cancer: mechanisms and disease progression. Biological Psychiatry 54:3, 269-282
CrossRef195
Robyn Lewis Claar, James A. Blumenthal. (2003) The value of stress-management interventions in life-threatening medical conditions. Current Directions in Psychological Science 12:4, 133-137
CrossRef196
Kerry S. Courneya, Christine M. Friedenreich, Rami A. Sela, H. Arthur Quinney, Ryan. E. Rhodes, Michael Handman. (2003) The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: Physical fitness and quality of life outcomes. Psycho-Oncology 12:4, 357-374
CrossRef197
B. Eliot Cole. (2003) The psychiatric management of end-of-life pain and associated psychiatric comorbidity. Current Pain and Headache Reports 7:2, 89-97
CrossRef198
Joshua Fogel, Steven M. Albert, Freya Schnabel, Beth Ann Ditkoff, Alfred I. Neugut. (2003) Racial/ethnic differences and potential psychological benefits in use of the internet by women with breast cancer. Psycho-Oncology 12:2, 107-117
CrossRef199
Pamela J. Goodwin. (2003) Psychosocial Support for Women with Advanced Breast Cancer. Breast Cancer Research and Treatment 81:S1, 103-110
CrossRef200
K. Kainz. (2003) Avoiding patient self-blame. Complementary Therapies in Medicine 11:1, 46-48
CrossRef201
P. J. Goodwin, J. T. Black, L. J. Bordeleau, P. A. Ganz. (2003) Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer--Taking Stock. JNCI Journal of the National Cancer Institute 95:4, 263-281
CrossRef202
Monica Keller, Joachim Weis, Andrea Schumacher, Barbara Griessmeier. (2003) Psycho-Oncology in a united Europe—changes and challenges. Critical Reviews in Oncology/Hematology 45:1, 109-117
CrossRef203
Kathryn L. Taylor, Ruth M. Lamdan, Jamie E. Siegel, Rebecca Shelby, Karen Moran-Klimi, Mary Hrywna. (2003) Psychological adjustment among African American breast cancer patients: One-year follow-up results of a randomized psychoeducational group intervention.. Health Psychology 22:3, 316-323
CrossRef204
Neil J. Farber, Susan Y. Urban, Virginia U. Collier, Joan Weiner, Ronald G. Polite, Elizabeth B. Davis, E. Gil Boyer. (2002) The Good News About Giving Bad News to Patients. Journal of General Internal Medicine 17:12, 914-922
CrossRef205
Wallace Sampson. (2002) Controversies in cancer and the mind: Effects of psychosocial support. Seminars in Oncology 29:6, 595-600
CrossRef206
Linda J. Luecken, Bruce E. Compas. (2002) Stress, coping, and immune function in breast cancer. Annals of Behavioral Medicine 24:4, 336-344
CrossRef207
Elizabeth F. Targ, Ellen G. Levine. (2002) The efficacy of a mind-body-spirit group for women with breast cancer: a randomized controlled trial. General Hospital Psychiatry 24:4, 238-248
CrossRef208
Tori Hudson. (2002) Alternative Medicine and Women's Health Issues: A Review of Recent Literature. Alternative and Complementary Therapies 8:3, 191-193
CrossRef209
(2002) Group Psychosocial Support in Metastatic Breast Cancer. New England Journal of Medicine 346:16, 1247-1248
Full Text210
Pamela J Goodwin. (2002) Group support in breast cancer: realistic hope, realistic benefits. Expert Review of Anticancer Therapy 2:2, 135-136
CrossRef211
Barbara L. Andersen. (2002) Biobehavioral outcomes following psychological interventions for cancer patients.. Journal of Consulting and Clinical Psychology 70:3, 590-610
CrossRef212
Timothy W. Smith, Philip C. Kendall, Francis J. Keefe. (2002) Behavioral medicine and clinical health psychology: Introduction to the special issue, a view from the decade of behavior.. Journal of Consulting and Clinical Psychology 70:3, 459-462
CrossRef213
Spiegel, David, . (2001) Mind Matters — Group Therapy and Survival in Breast Cancer. New England Journal of Medicine 345:24, 1767-1768
Full Text
